Literature DB >> 9875091

A follow up study of myocardial involvement in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS).

Y Okajima1, Y Tanabe, M Takayanagi, H Aotsuka.   

Abstract

OBJECTIVE: To investigate cardiac function in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes (MELAS) and clarify the clinical features of cardiomyopathy in MELAS. PATIENTS: 11 consecutive patients with MELAS (mean age at initial examination 11.3 years, range 4 to 16 years) were enrolled in the study. Six were followed for more than five years.
RESULTS: On echocardiographic examination, three patients showed increased left ventricular end diastolic posterior wall thickness (LVPWTd), exceeding 140% of the normal value. Four patients, including these three, had an ejection fraction of less than 50%, and two also had increased left ventricular end diastolic volume (LVEDV) exceeding 140% of the normal value (%N). The LVPWTd%N was correlated positively with the LVEDV%N (R = 0.669, p < 0.05) and negatively with the ejection fraction (R = -0.6701, p < 0.05). One patient died of heart failure aged 22 years.
CONCLUSIONS: The cardiomyopathy in MELAS is characterised by an abnormally thick left ventricular wall with progressive dilatation and poor left ventricular contraction developing over several years, indicating hypertrophic cardiomyopathy advancing to dilated cardiomyopathy.

Entities:  

Mesh:

Year:  1998        PMID: 9875091      PMCID: PMC1761104          DOI: 10.1136/hrt.80.3.292

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  22 in total

Review 1.  Natural history of hypertrophic cardiomyopathy.

Authors:  P Spirito; P Bellone
Journal:  Br Heart J       Date:  1994-12

2.  Risk factors and stratification for sudden cardiac death in patients with hypertrophic cardiomyopathy.

Authors:  B J Maron; F Cecchi; W J McKenna
Journal:  Br Heart J       Date:  1994-12

3.  Comparison of the relative levels of the 3243 (A-->G) mtDNA mutation in heteroplasmic adult and fetal tissues.

Authors:  P M Matthews; J Hopkin; R M Brown; J B Stephenson; D Hilton-Jones; G K Brown
Journal:  J Med Genet       Date:  1994-01       Impact factor: 6.318

4.  Accumulation of somatic nucleotide substitutions in mitochondrial DNA associated with the 3243 A-to-G tRNA(leu)(UUR) mutation in encephalomyopathy and cardiomyopathy.

Authors:  S A Kovalenko; M Tanaka; M Yoneda; A F Iakovlev; T Ozawa
Journal:  Biochem Biophys Res Commun       Date:  1996-05-15       Impact factor: 3.575

5.  Point mutation of the mitochondrial tRNA(Leu) gene (A 3243 G) in maternally inherited hypertrophic cardiomyopathy, diabetes mellitus, renal failure, and sensorineural deafness.

Authors:  S Manouvrier; A Rötig; G Hannebique; J D Gheerbrandt; G Royer-Legrain; A Munnich; M Parent; J P Grünfeld; C Largilliere; A Lombes
Journal:  J Med Genet       Date:  1995-08       Impact factor: 6.318

6.  Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries.

Authors:  A Pasternac; J Noble; Y Streulens; R Elie; C Henschke; M G Bourassa
Journal:  Circulation       Date:  1982-04       Impact factor: 29.690

7.  Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy.

Authors:  B J Maron; J K Wolfson; S E Epstein; W C Roberts
Journal:  J Am Coll Cardiol       Date:  1986-09       Impact factor: 24.094

8.  Cardiomyopathy and angiopathy in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes.

Authors:  W Sato; M Tanaka; S Sugiyama; T Nemoto; K Harada; Y Miura; Y Kobayashi; A Goto; G Takada; T Ozawa
Journal:  Am Heart J       Date:  1994-10       Impact factor: 4.749

9.  Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.

Authors:  R O Cannon; D R Rosing; B J Maron; M B Leon; R O Bonow; R M Watson; S E Epstein
Journal:  Circulation       Date:  1985-02       Impact factor: 29.690

10.  Mitochondrial encephalomyopathy with A to G transition of mitochondrial transfer RNA(Leu(UUR)) 3,243 presenting hypertrophic cardiomyopathy.

Authors:  Y Hiruta; K Chin; K Shitomi; T Ichihara; M Mochizuki; K Adachi; T Obayashi; M Tanaka; T Ozawa
Journal:  Intern Med       Date:  1995-07       Impact factor: 1.271

View more
  16 in total

Review 1.  MELAS syndrome and cardiomyopathy: linking mitochondrial function to heart failure pathogenesis.

Authors:  Ying-Han R Hsu; Haran Yogasundaram; Nirmal Parajuli; Lucas Valtuille; Consolato Sergi; Gavin Y Oudit
Journal:  Heart Fail Rev       Date:  2016-01       Impact factor: 4.214

2.  Cardiovascular Complications of Neuromuscular Disorders.

Authors:  Bhavesh Sachdev; Perry M. Elliott; William J. McKenna
Journal:  Curr Treat Options Cardiovasc Med       Date:  2002-04

3.  Altered Cardiac Energetics and Mitochondrial Dysfunction in Hypertrophic Cardiomyopathy.

Authors:  Sara Ranjbarvaziri; Kristina B Kooiker; Mathew Ellenberger; Giovanni Fajardo; Mingming Zhao; Alison Schroer Vander Roest; Rahel A Woldeyes; Tiffany T Koyano; Robyn Fong; Ning Ma; Lei Tian; Gavin M Traber; Frandics Chan; John Perrino; Sushma Reddy; Wah Chiu; Joseph C Wu; Joseph Y Woo; Kathleen M Ruppel; James A Spudich; Michael P Snyder; Kévin Contrepois; Daniel Bernstein
Journal:  Circulation       Date:  2021-10-21       Impact factor: 39.918

4.  A case of mitochondrial cardiomyopathy with pericardial effusion evaluated by (99m)Tc-MIBI myocardial scintigraphy.

Authors:  Noriyuki Yajima; Yoshikazu Yazaki; Kunihiro Yoshida; Kenji Sano; Wataru Takahashi; Yasuyuki Sasaki; Uichi Ikeda
Journal:  J Nucl Cardiol       Date:  2009 Nov-Dec       Impact factor: 5.952

5.  A Case of Myopathy, Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS) Syndrome with Intracardiac Thrombus [corrected].

Authors:  Jung-Chul Joo; Myung Do Seol; Jin Won Yoon; Young Soo Lee; Dong-Keun Kim; Yong Hoon Choi; Hyo Seong Ahn; Wook Hyun Cho
Journal:  Korean Circ J       Date:  2013-03-31       Impact factor: 3.243

6.  Cardiac scintigraphic findings of mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: A case report.

Authors:  Shinro Matsuo; Kenichi Nakajima; Seigo Kinuya; Yuichi Sato; Naoya Matsumoto; Minoru Horie
Journal:  Exp Clin Cardiol       Date:  2008

7.  Pulmonary artery hypertension in a child with MELAS due to a point mutation of the mitochondrial tRNA((Leu)) gene (m.3243A>G).

Authors:  D M Sproule; J Dyme; J Coku; D de Vinck; E Rosenzweig; W K Chung; D C De Vivo
Journal:  J Inherit Metab Dis       Date:  2008-01-07       Impact factor: 4.982

8.  Proteomic and metabolomic advances uncover biomarkers of mitochondrial disease pathophysiology and severity.

Authors:  Marjan Gucek; Michael N Sack
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

Review 9.  Cardiac involvement in mitochondrial DNA disease: clinical spectrum, diagnosis, and management.

Authors:  Matthew G D Bates; John P Bourke; Carla Giordano; Giulia d'Amati; Douglass M Turnbull; Robert W Taylor
Journal:  Eur Heart J       Date:  2012-08-30       Impact factor: 29.983

Review 10.  Molecular Epidemiology of Mitochondrial Cardiomyopathy: A Search Among Mitochondrial and Nuclear Genes.

Authors:  Cristina Mazzaccara; Bruno Mirra; Ferdinando Barretta; Martina Caiazza; Barbara Lombardo; Olga Scudiero; Nadia Tinto; Giuseppe Limongelli; Giulia Frisso
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.